Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3422)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2023 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW, Chen DX. Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol 2023; 15(4): 460-476 [PMID: 37206651 DOI: 10.4254/wjh.v15.i4.460] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v15/i4/460.htm |
| Number | Citing Articles |
| 1 |
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
|
| 2 |
Yong-Gang He, Zheng Wang, Jing Li, Wang Xi, Chong-Yu Zhao, Xiao-Bing Huang, Lu Zheng. Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report. World Journal of Gastrointestinal Oncology 2024; 16(11): 4506-4513 doi: 10.4251/wjgo.v16.i11.4506
|
| 3 |
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen. Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences 2023; 25(1): 433 doi: 10.3390/ijms25010433
|
| 4 |
Shiheng Wu, Xinxing Zhang, Jin Bao, Naiying Sun, Wenjun Guo, Baogui Wang, Xingjie Yang. Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report. Oncology Letters 2023; 27(2) doi: 10.3892/ol.2023.14207
|
| 5 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(343) |
Core Tip(344) |
Full Article(HTML)(1628)
|
Full Article with Cover (PDF)-3548K(124)
|
Full Article (Word)-242K(21)
|
Audio-234K(10)
|
Peer-Review Report-224K(68)
|
Answering Reviewers-264K(55)
|
Full Article (PDF)-550K(111)
|
Full Article (XML)-38K(46)
|
Times Cited (2)
|
Total Visits (4034)
|
Open
|
| 6 |
Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis. Genomics 2024; 116(3): 110831 doi: 10.1016/j.ygeno.2024.110831
|
| 7 |
Ravi Parhar, Prakash Ramachandran. Sinusoidal Cells in Liver Diseases. 2024; : 111 doi: 10.1016/B978-0-323-95262-0.00006-1
|
| 8 |
Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv. An Overview of the Deubiquitinase USP53: A Promising Diagnostic
Marker and Therapeutic Target. Current Protein & Peptide Science 2024; 25(9): 708 doi: 10.2174/0113892037292440240518194922
|